| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.63B | — | +21.9% |
| Cost of Revenue | $1.18B | — | +19.4% |
| Gross Profit | $447.0M | — | +29.2% |
| R&D Expense | $97.0M | — | +15.5% |
| SG&A Expense | $84.0M | — | +6.3% |
| Operating Income | $110.0M | — | +155.8% |
| Pre-tax Income | $131.0M | — | +125.9% |
| Income Tax | $5.0M | — | +150.0% |
| Net Income | $126.0M | — | +125.0% |
| EPS (Basic) | $0.21 | — | +110.0% |
| EPS (Diluted) | $0.20 | — | +122.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.10B | -18.8% | +9.3% |
| Accounts Receivable | $138.0M | +8.7% | +16.9% |
| Inventory | $136.0M | +19.3% | +22.5% |
| Current Assets | $2.59B | -2.9% | +22.1% |
| Total Assets | $3.09B | -1.6% | +20.7% |
| Current Liabilities | $1.06B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $132.0M | — | +67.1% |
| Investing Cash Flow | -$75.0M | — | -440.9% |
| Financing Cash Flow | -$227.0M | — | -411.0% |
| +26.1% |
| Total Liabilities | $1.10B | +8.1% | +23.9% |
| Stockholders' Equity | $1.99B | -6.3% | +18.9% |